Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder-Reference-Cited by-同舟云学术

Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder

Published:2021-09-12 Issue:11 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Dean Rebecca L¹,Hurducas Claudia¹,Hawton Keith²,Spyridi Styliani³,Cowen Philip J⁴,Hollingsworth Sarah¹,Marquardt Tahnee¹,Barnes Annabelle¹,Smith Rebecca¹,McShane Rupert¹⁴,Turner Erick H⁵⁶,Cipriani Andrea¹⁴

Affiliation:

1. Oxford Health NHS Foundation Trust; Oxford UK

2. Centre for Suicide Research, Department of Psychiatry; University of Oxford; Oxford UK

3. Department of Rehabilitation Sciences, Faculty of Health Sciences; Cyprus University of Technology; Lemesos Cyprus

4. Department of Psychiatry; University of Oxford; Oxford UK

5. Portland Veterans Affairs Medical Center; P3MHDC; Portland USA

6. Department of Psychiatry; Oregon Health & Science University; Portland Oregon USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference236 articles.

1. Memantine in the prevention or alleviation of electroconvulsive therapy induces cognitive disorders: a placebo controlled trial;Abbasinazari;Asian Journal of Psychiatry,2015

2. Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: ramdomized, double-blind, placebo-controlled study;Amidfar;Journal of Clinical Pharmacy and Therapeutics,2016

3. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial;Anderson;Lancet Psychiatry,2017

4. Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial;Arabzadeh;Journal of Affective Disorders,2018

5. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial;Berk;Journal of Clinical Psychiatry,2014

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prefrontal cortex astrocytes in major depressive disorder: exploring pathogenic mechanisms and potential therapeutic targets;Journal of Molecular Medicine;2024-09-14

2. Ketamine and α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Receptor Potentiation in the Somatosensory Cortex: A Comprehensive Review;Cureus;2024-09-12

3. Perioperative esketamine administration for prevention of postpartum depression after the cesarean section: A systematic review and meta-analysis;Journal of Affective Disorders;2024-09

4. Management of Depression in Adults;JAMA;2024-07-09

5. New and emerging treatments for major depressive disorder;BMJ;2024-07-08